1 From the Departments of Pediatrics, Medicine, Biometry and Genetics, and Biochemistry, Louisiana State University Medical Center, New Orleans
The use of serum total cholesterol measurement was evaluated as a screening tool to predict elevated levels of low-density lipoprotein cholesterol in 2857 children and adolescents, aged 5 to 17 years, examined in 1981 and 1982. Subjects were from the biracial community of Bogalusa, Louisiana. For selected serum total cholesterol values (150 to 210 mg/dL, 3.88 to 5.43 mmol/L), sensitivities were higher for blacks than whites and higher for females than males, whereas the positive predictive values were higher for whites than blacks and higher for males than females. With the age-, race-, and sex-specific 95th percentiles of serum total cholesterol levels as cutoff points, only 44% to 50% of subjects with elevated low-density lipoprotein cholesterol levels (
95th percentile) were detected, and approximately 50% of those identified had false-positive results. Lowering the serum total cholesterol cutoff point increased the sensitivity, but decreased the specificity and positive predictive value. At the 75th percentiles of serum total cholesterol levels, sensitivities were 92% to 95% for females and 100% for males and specificities were 78% to 79%, but the false-positive results increased to 81% to 84%. The low cost and ease of obtaining serum total cholesterol measurements contribute to its appeal as a screening tool for hyperlipidemia. However, its poor test characteristics make serum total cholesterol measurement inefficient as a screening tool for detecting elevated levels of low-density lipoprotein cholesterol in children and adolescents.
Key Words: cardiovascular diseases lipoproteins cholesterol low-density-lipoprotein cholesterol
Submitted on November 16, 1988
Accepted on May 17, 1989
This article has been cited by other articles:
![]() |
E. M. Haney, L. H. Huffman, C. Bougatsos, M. Freeman, R. D. Steiner, and H. D. Nelson Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force Pediatrics, July 1, 2007; 120(1): e189 - e214. [Abstract] [Full Text] [PDF] |
||||
![]() |
US Preventive Services Task Force Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement Pediatrics, July 1, 2007; 120(1): e215 - e219. [Full Text] [PDF] |
||||
![]() |
B. W. McCrindle, E. M. Urbina, B. A. Dennison, M. S. Jacobson, J. Steinberger, A. P. Rocchini, L. L. Hayman, and S. R. Daniels Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing Circulation, April 10, 2007; 115(14): 1948 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Belay, P. Belamarich, and A. D. Racine Pediatric Precursors of Adult Atherosclerosis Pediatr. Rev., January 1, 2004; 25(1): 4 - 16. [Full Text] [PDF] |
||||
![]() |
K. Schulpis and G. A. Karikas Serum Cholesterol and Triglyceride Distribution in 7767 School-aged Greek Children Pediatrics, May 1, 1998; 101(5): 861 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Nader, M. Yang, R. V. Luepker, G. S. Parcel, P. Pirie, H. A. Feldman, E. J. Stone, and L. S. Webber Parent and Physician Response to Children's Cholesterol Values of 200 mg/dL or Greater: The Child and Adolescent Trial for Cardiovascular Health Experiment Pediatrics, May 1, 1997; 99(5): e5 - e5. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. DeClue and D. M. Schocken Cholesterol Screening Management of Florida's Pediatric Population Clinical Pediatrics, June 1, 1991; 30(6): 340 - 342. [Abstract] [PDF] |
||||